Valvular Heart Disease in Patients Taking Pergolide
Authors:
- John F. MorrisonJMJohn F. Morrison
- William D. EdwardsWEWilliam D. Edwards
- Hartzell V. SchaffHSHartzell V. Schaff
- Heidi M. ConnollyHCHeidi M. Connolly
- Raul E. EspinosaRERaul E. Espinosa
- 1 December 2002
- journal article
- case report
- Published by Elsevier in Mayo Clinic Proceedings
- Vol. 77 (12) , 1280-1286
Abstract
No abstract availableKeywords
This publication has 24 references indexed in Scilit:
- Practice Parameters for the Treatment of Restless Legs Syndrome and Periodic Limb Movement DisorderSLEEP, 1999
- Pericardial, retroperitoneal, and pleural fibrosis induced by pergolideJournal of Neurology, Neurosurgery & Psychiatry, 1999
- Valvular Heart Disease Associated with Fenfluramine–PhentermineNew England Journal of Medicine, 1997
- Carcinoid Heart DiseaseCirculation, 1995
- Retroperitoneal Fibrosis in a Patient with Parkinsonʼs Disease Treated with PergolideClinical Neuropharmacology, 1995
- Valve Disease Associated with Ergot Alkaloid Use: Echocardiographic and Pathologic CorrelationsAnnals of Internal Medicine, 1992
- Surgical Pathology of the Tricuspid Valve: A Study of 363 Cases Spanning 25 YearsMayo Clinic Proceedings, 1988
- Cardiac murmurs and endocardial fibrosis associated with methysergide therapyAmerican Heart Journal, 1974
- CARDIAC AND PULMONARY FIBROSIS DURING METHYSERGIDE THERAPY FOR HEADACHEThe American Journal of the Medical Sciences, 1967
- Fibrotic Disorders Associated with Methysergide Therapy for HeadacheNew England Journal of Medicine, 1966